Attached files
file | filename |
---|---|
EX-31.2 - eWELLNESS HEALTHCARE Corp | ex31-2.htm |
EX-32.1 - eWELLNESS HEALTHCARE Corp | ex32-1.htm |
EX-31.1 - eWELLNESS HEALTHCARE Corp | ex31-1.htm |
EX-32.2 - eWELLNESS HEALTHCARE Corp | ex32-2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A1
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 000-55203
eWELLNESS HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
Nevada | 90-1073143 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
11825 Major Street, Culver City, California | 90230 | |
(Address of principal executive offices) | (Zip Code) |
(310) 915-9700
(Registrant’s telephone number, including area code)
Copies of Communications to:
Louis Taubman, Esq.
Hunter Taubman Weiss
130 West 42nd Street, Floor 10
New York, NY 10036
P: 917-512-0828
F: 212-202-6380
Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Ruble 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated filer [ ] (Do not check if a smaller reporting company) | Smaller reporting company [X] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
The number of shares of Common Stock, $0.001 par value, outstanding on May 12, 2015 was 16,881,000 shares.
EXPLANATORY NOTE
We are filing this Amendment No.1 (the “Amended Report”) to our quarterly report on Form 10-Q for the period ended March 31, 2015 we filed on May 12, 2015 (“the “Original Report”) to correct an error contained in the cover page to uncheck the box designating the company as a shell company and to provide a new I.R.S. Employer identification number recently assigned to us. This Amendment Report does not reflect events that may have occurred after the filing of t he Original Report, nor does it modify or update those disclosures present therein, except with regard to the modification described in this Explanatory Note. As such, this Amendment Report continues to speak to as of May 12, 2015. Accordingly, this Amended Report should be read in conjunction with the Original Report and our other reports filed with the SEC subsequent to the filing of our Original Report, including any amendments to those filings.
In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as a result of this Amended Report, the certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley of 2002, filed and furnished, respectively, as exhibits to the Original Report have been re-executed and re-filed as of the date of this Amended Report and are included as exhibits hereto.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
eWellness Healthcare Corporation | ||
Date: March 11, 2016 | By: | /s/ Darwin Fogt |
Darwin Fogt Director and Chief Executive Officer (Principal Executive Officer) | ||
Date: March 11, 2016 | By: | /s/ David Markowski |
David Markowski, Chief Financial Officer (Principal Financial and Accounting Officer) |
3 |